Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Karex Bhd's average EBITDA Per Share Growth Rate was 12.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -42.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -19.00% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -12.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Karex Bhd was 71.00% per year. The lowest was -42.40% per year. And the median was -3.85% per year.
Karex Bhd (XKLS:5247) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Karex Bhd 5-Year EBITDA Growth Rate Related Terms
XKLS:5247 vs PG, CL, EL: 5-Year EBITDA Growth Rate Comparison
For the Household & Personal Products subindustry, Karex Bhd's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Karex Bhd 5-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Karex Bhd's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Karex Bhd's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of -19.00% mean?
Karex Bhd (XKLS:5247) has a 5-Year EBITDA Growth Rate of -19.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Karex Bhd and its competitors.
Is Karex Bhd's 5-Year EBITDA Growth Rate too high?
Karex Bhd's current 5-Year EBITDA Growth Rate is -19.00%. Overall, Karex Bhd has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Karex Bhd's 5-Year EBITDA Growth Rate compare to PG and CL?
Karex Bhd's 5-Year EBITDA Growth Rate of -19.00% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
A good 5-Year EBITDA Growth Rate depends on the Consumer Packaged Goods industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Karex Bhd and its competitors. Karex Bhd's current 5-Year EBITDA Growth Rate is -19.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Karex Bhd stock overvalued right now?
Based on GuruFocus' analysis, Karex Bhd (XKLS:5247) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.73, compared to a current price of RM0.47 — trading 35.6% below its estimated fair value. The current 5-Year EBITDA Growth Rate is -19.00%. Karex Bhd's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Karex Bhd (XKLS:5247), the current 5-Year EBITDA Growth Rate is -19.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Karex Bhd (XKLS:5247) Overvalued in 2026?
Based on GuruFocus' analysis, Karex Bhd stock appears to be undervalued.
The current stock price of RM0.47 is trading 35.6% below its estimated GF Value™ of RM0.73.
GuruFocus considers Karex Bhd to be Possible Value Trap.
Key valuation signals for XKLS:5247:
5-Year EBITDA Growth Rate: -19.00%
GF Value™: RM0.73 vs. price of RM0.47 (35.6% below fair value)
No single metric tells the full story. See the XKLS:5247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Karex Bhd is a Malaysian investment holding company. Along with its subsidiaries, its main business activities comprise investment holding, manufacture, and sale of sexual wellness, medical, and other health-related products. These activities are located in Malaysia, Thailand, the United States of America, and the United Kingdom. It is principally engaged in manufacturing and selling condoms, personal lubricants, latex probe covers, oral dams, and others. The operating segments of the company are Sexual wellness, which generates maximum profits, Medical, and Others. Geographically, it derives key revenue from the Americas and the rest from Asia, Europe, and Africa.
39GF Score
Get the complete analysis for XKLS:5247
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5247 has been successfully added to your 
